CDSCO issued the List of Drugs declared as Not of Standard Quality for the Month of October– 2023

Nov 21, 2023 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00

Industry Specific ComplianceThe Central Drugs Standard Control Organization (CDSCO) on November 20, 2023, issued the List of Drugs, Medical Devices, and Cosmetics declared as Not of Standard Quality/Spurious/Adulterated/Misbranded for the Month of October – 2023.

The following Drugs/medical device/cosmetics has been declared not of standard namely:

• Cefixime Oral Suspension IP

• Fluconazole Tablets IP (Aclohix-400 Tablets)

• Digoxin Injection BP (Digiver Injection)

• Propylene Glycol IP

• Diclofenac Sodium Tablets IP 50 mg

 

For further information, kindly refer to the document attached.

View Document 1

Bookmark

Related Updates

View More Related Updates


Alternate Text

Get updates on the go on RegUpdate Mobile App.

Alternate Text
✦ NEW  ·  AI ASSISTANT